appliedclinicaltrialsonline5h
Kazia Therapeutics Launches Clinical Trial Evaluating Paxalisib in Combination with Keytruda or Lynparza for the Treatment of Advanced Breast Cancer
John Friend, MD, CEO of Kazia Therapeutics added, "The novelty of the science that Professor Rao has proposed with this dual ...
appliedclinicaltrialsonline7h
Bexicaserin Produces Significant Seizure Reduction in PACIFIC OLE Trial for Developmental and Epileptic Encephalopathies
The 12-month open-label extension of the PACIFIC trial demonstrated that bexicaserin significantly reduced seizure frequency ...
appliedclinicaltrialsonline11h
Filling Evidence Gaps in Clinical Research
In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, discusses how MMRF ...
appliedclinicaltrialsonline22h
Matthew Ryan
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...